C19H14Cl2N2O3S
421.3 g/mol
APIDanger
Vismodegib
CAS879085-55-9
Category
API
Compound Class
Amide
Primary Use
Pharmaceutical Raw Material
Vismodegib is an active pharmaceutical ingredient used in antineoplastic medications. According to authoritative sources, it is associated with developmental toxicity and reproductive toxicity risks.
Antineoplastic medication
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 879085-55-9
Related Compounds
ReferenceSame Category
Des(1-hydroxy-1-methylethyl)-(1-methylethenyl)-olmesartan medoxomil
CAS879562-26-2
pharmaceutical raw material
ReferenceSame Category
Chloroxylenol
CAS88-04-0
pharmaceutical raw material
ReferenceSame Category
N-adamantylacetamide
CAS880-52-4
pharmaceutical raw material
ReferenceSame Category
Cefepime
CAS88040-23-7
pharmaceutical raw material
Safety Reference
Danger
H302Harmful if swallowed
H312Harmful in contact with skin
H332Harmful if inhaled
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
H360May damage fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide
InChIKey
BPQMGSKTAYIVFO-UHFFFAOYSA-N
SMILES
CS(=O)(=O)C1=CC(=C(C=C1)C(=O)NC2=CC(=C(C=C2)Cl)C3=CC=CC=N3)Cl
Synonyms (25)
- R-3616
- V-4050
- VIS
- Vismodegib (USAN/INN)
- Erivedge
- Erivedge (TN)
- Hedgehog Antagonist GDC-0449
- HhAntag 691
- R3616 cpd
- Vismodegib
- Vismodegib (GDC-0449)
- Vismodegib (Standard)
- Vismodegib, free base
- methanesulfonylbenzamide
- vismodegibum